Navigation Links
'Protected Classes' Prescription Drug Mandates Would Hike Small Business Costs, Drug Company Profits
Date:7/18/2012

WASHINGTON, July 18, 2012 /PRNewswire-USNewswire/ -- Imposing a federal "protected classes" prescription drug mandate on individual and small employer plans would raise premiums, grant drug companies unlimited pricing power, and create strong opposition from small businesses, the Pharmaceutical Care Management Association (PCMA) said today.  The Centers for Medicare & Medicaid Services (CMS) says a similar mandate is dramatically increasing costs in Medicare Part D.

In the commercial market, employers and unions negotiate discounts from drug companies in exchange for covering their drugs.  This reduces premiums and offers manufacturers a greater marketplace.  To simply force plans to cover expensive brands – regardless of price – would eliminate manufacturers' incentives to offer discounts.  The result would be higher costs and virtually unchecked pricing power for drug companies.

Unfortunately, "protected classes" regulations have already taken their toll on Medicare Part D.  CMS estimates that they will increase costs by $4.2 billion.  There is no corresponding evidence that Medicare beneficiaries' health or access to care has improved as a result.

In a recent survey, 66% of small employers say "cost" is their top consideration when considering health benefits.  Imposing "protected classes" would not only undermine affordability but also contradict the Department of Health and Human Services' (HHS) pronouncement that states can design benefits like those of popular, high-performing plans that local employers already use.  No such plans are governed by "protected classes" regulations.

"These 'protected class' mandates would grant drug companies unlimited pricing power and make coverage less affordable for individuals and small businesses.  Small businesses shouldn't have to choose between a bloated Cadillac plan and no plan at all.  They want access to affordable plans that offer broad coverage, promote generics, and reduce brand name drug costs," said PCMA President and CEO Mark Merritt.

The poll of small business owners and human resource managers (who represent the companies directly impacted by the upcoming Essential Health Benefits regulations) found that:

  • Small businesses want low-cost coverage options, not mandatory "Cadillac coverage." Their top priorities are low pharmacy costs for their business (66 percent) and lower out-of-pocket costs for their employees (39 percent). Given a choice, they prefer basic coverage with lower premiums (71 percent) to expanded coverage with higher premiums (19 percent).
  • Small businesses that provide drug benefits are overwhelmingly satisfied with the benefits that they are able to offer. By an 86 to 11 percent margin, small businesses that provide drug benefits are satisfied with those benefits.
  • Seventy-four percent oppose mandating across-the-board, low co-pays for high-priced drugs. By a 2-1 margin, small businesses think it would be better to require drug companies to offer case-by-case price discounts to those in need.
  • Small businesses want access to plans that encourage delivery of prescription drugs through the mail. 79 percent say it is a good idea to "allow plans to offer discounts that encourage employees to get prescriptions by mail."

The survey echoes concerns outlined by the Essential Health Benefits Coalition (an employer led coalition comprised of the National Federation of Independent Business, the National Retail Federation, and others) and Administration policy that commercial practice would be the benchmark for essential health benefits for prescription drugs.

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve
affordability and quality of care through the use of electronic prescribing (e-prescribing),
generic alternatives, mail-service pharmacies, and other innovative tools for 216 million Americans.

Follow PCMA on Twitter


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan: Launch of New Classes of Oral Antidiabetic Drugs by 2014 will Uplift Prospects for the European Diabetes Therapeutics Market
2. President Obama Signs Landmark Accessible Prescription Drug Label Bill
3. New Video, Website Help Health Plan Sponsors, Patients and Policy Makers Maximize Prescription Drug Benefits, Reduce Wasteful Spending
4. Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
5. Partnership Aims to Prevent Students from Misusing Prescription Drugs
6. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
7. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
8. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
9. Parent Project Muscular Dystrophy Endorses Senate Version of Prescription Drug User Fee Act After Patient Voice Strengthened
10. Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway
11. Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administrations Nationwide Prescription "Drug Take-Back Day"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Medical Market Analysis 2016 - Forecast to 2022" report ... The report contains up to date financial data derived from ... of major trends with potential impact on the market during ... market segmentation which comprises of sub markets, regional and country ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):